Magzter GOLD ile Sınırsız Olun
Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin
Denemek ALTIN - Özgür
Cipla Bets Big on Weight-Loss Drug Market in India
Mint New Delhi
|July 26, 2025
The patent for Semaglutide is expiring in countries such as India, Canada, and Brazil in 2026
Drugmaker Cipla Ltd anticipates GLP-1 drugs, used for treating type-2 diabetes and obesity, to be a definite new therapy in the Indian market, and is exploring a wider foray, said chief executive Umang Vohra.
"The Indian market is particularly important to us, where we're looking at the whole GLP-1 category and not just Semaglutide alone," Vohra told reporters on Friday after the company declared its June-quarter results.
Semaglutide, a GLP-1 (glucagon-like peptide-1) drug sold under the brand name Wegovy in India by Novo Nordisk, goes off patent in March 2026.
Bu hikaye Mint New Delhi dergisinin July 26, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint New Delhi'den DAHA FAZLA HİKAYE
Mint New Delhi
Ola rolls out non-AC rides pan-India
The new category creates significant opportunities for drivers, the firm said.
1 min
December 03, 2025
Mint New Delhi
SC upholds RIL fine on Jio-Facebook deal
The Supreme Court on Tuesday rejected Reliance Industries Ltd’s (RIL) appeal against a Securities Appellate Tribunal (SAT) order that had upheld a ₹30-lakh penalty on two of its compliance officers for the delayed disclosure of the ₹43,574-crore Facebook-Jio investment deal in 2020.
2 mins
December 03, 2025
Mint New Delhi
Time, and not capital, isa disruptor: Wakefit founder
The IPO-bound company has developed an asset-light approach to building offline presence
2 mins
December 03, 2025
Mint New Delhi
Centre clears 2.9k buses in PM E-Drive
The Union heavy industries ministry on Tuesday announced the allocation of 2,900 new electric buses in the second phase of the PM E-Drive scheme’s tender, according to a disclosure in the Lok Sabha.
1 min
December 03, 2025
Mint New Delhi
Meesho under fire from investors over SBI Funds allotment
Meesho Ltd's anchor book faced a setback after several major investors pulled out when the Indian e-commerce firm was said to have allocated about a quarter of the shares in this tranche to SBI Funds Management Pvt,, the country’s largest asset manager, according to people familiar with the matter.
1 mins
December 03, 2025
Mint New Delhi
India pulls 7 quality orders, revamps telecom standards
The moves ease compliance and mark a shift towards modernizing India’s technical rulebook
2 mins
December 03, 2025
Mint New Delhi
Pernod Ricard exits Imperial to bet big on premium spirits
French spirits major Pernod Ricard India is sharpening its focus on premium alcohol, exiting the mass-market whisky segment even as it launches a new India-made brand aimed at consumerstrading up.
2 mins
December 03, 2025
Mint New Delhi
Sitharaman urges global action on new economic risks
The finance minister said that economic governance must rest on fairness and responsibility
1 mins
December 03, 2025
Mint New Delhi
Chander assumes charge as LIC MD
Ramakrishnan Chander has been elevated to the position of managing director (MD) of Life Insurance Corporation of India (LIC).
1 min
December 03, 2025
Mint New Delhi
Maruti eyes EV edge as it drives India push with charging infra
Maruti Suzuki India Ltd aims to lead the electric vehicle (EV) race by establishing 100,000 charging points and 1,500 service workshops across India, backed by a 150,000-strong trained workforce, by 2030.
1 mins
December 03, 2025
Listen
Translate
Change font size